Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (133) 133
life sciences & biomedicine (131) 131
humans (125) 125
female (105) 105
oncology (104) 104
male (103) 103
middle aged (91) 91
aged (79) 79
adult (78) 78
biological and medical sciences (60) 60
medical sciences (59) 59
aged, 80 and over (48) 48
tumors (36) 36
prognosis (32) 32
retrospective studies (32) 32
abridged index medicus (29) 29
treatment outcome (29) 29
lung neoplasms - genetics (28) 28
carcinoma, non-small-cell lung - drug therapy (27) 27
lung neoplasms - drug therapy (26) 26
pneumology (26) 26
tumors of the respiratory system and mediastinum (26) 26
lung neoplasms - pathology (25) 25
mutation (25) 25
surgery (25) 25
carcinoma, non-small-cell lung - genetics (24) 24
hematology, oncology and palliative medicine (23) 23
neoplasm staging (23) 23
radiotherapy (23) 23
young adult (23) 23
care and treatment (22) 22
radiology, nuclear medicine & medical imaging (22) 22
survival rate (22) 22
follow-up studies (21) 21
adolescent (20) 20
antineoplastic agents (19) 19
pharmacology. drug treatments (19) 19
research (19) 19
carcinoma, non-small-cell lung - pathology (18) 18
lung neoplasms - mortality (18) 18
radiation (18) 18
risk factors (18) 18
survival analysis (18) 18
receptor, epidermal growth factor - genetics (17) 17
time factors (17) 17
chemotherapy (16) 16
lung cancer (16) 16
analysis (15) 15
kaplan-meier estimate (15) 15
prospective studies (15) 15
child, preschool (14) 14
patient outcomes (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
protein kinase inhibitors - therapeutic use (13) 13
respiratory system (13) 13
alk (12) 12
cancer (12) 12
carcinoma, non-small-cell lung - mortality (12) 12
child (12) 12
erlotinib hydrochloride (12) 12
proton therapy - adverse effects (12) 12
adenocarcinoma - genetics (11) 11
adenocarcinoma - pathology (11) 11
animals (11) 11
antineoplastic agents - therapeutic use (11) 11
combined modality therapy (11) 11
genotype (11) 11
hematology (11) 11
mesothelioma (11) 11
patients (11) 11
radiology (11) 11
transplantation (11) 11
disease-free survival (10) 10
immunohistochemistry (10) 10
lung cancer, non-small cell (10) 10
medical research (10) 10
proton therapy - methods (10) 10
quinazolines - therapeutic use (10) 10
radiology and nuclear medicine (10) 10
cell line, tumor (9) 9
disease progression (9) 9
mesothelioma - pathology (9) 9
non-small cell lung cancer (9) 9
pathology (9) 9
pediatrics (9) 9
pleural neoplasms - pathology (9) 9
protons - therapeutic use (9) 9
radiotherapy dosage (9) 9
carcinoma, non-small-cell lung - metabolism (8) 8
diagnosis (8) 8
gene expression (8) 8
in situ hybridization, fluorescence (8) 8
infant (8) 8
lung neoplasms - diagnosis (8) 8
lung neoplasms - metabolism (8) 8
medicine, experimental (8) 8
mesothelioma - mortality (8) 8
mice (8) 8
neoplasms (8) 8
photons - therapeutic use (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
by Shaw, Alice T, Dr and Yeap, Beow Y, ScD and Solomon, Benjamin J, MD and Riely, Gregory J, MD and Gainor, Justin, MD and Engelman, Jeffrey A, MD and Shapiro, Geoffrey I, MD and Costa, Daniel B, MD and Ou, Sai-Hong I, MD and Butaney, Mohit, BS and Salgia, Ravi, Prof and Maki, Robert G, MD and Varella-Garcia, Marileila, Prof and Doebele, Robert C, MD and Bang, Yung-Jue, Prof and Kulig, Kimary, PhD and Selaru, Paulina, MSPH and Tang, Yiyun, PhD and Wilner, Keith D, PhD and Kwak, Eunice L, MD and Clark, Jeffrey W, MD and Iafrate, A John, MD and Camidge, D Ross, MD
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 11, pp. 1004 - 1012
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Lung Neoplasms - mortality | United States | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Patient Selection | Multicenter Studies as Topic | Time Factors | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Retrospective Studies | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Risk Assessment | Carcinoma, Non-Small-Cell Lung - genetics | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Receptor Protein-Tyrosine Kinases - genetics | Protein Kinase Inhibitors - therapeutic use | Gene Rearrangement | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Australia | Clinical Trials, Phase I as Topic | Care and treatment | Analysis | Patient outcomes | Genetic research | Genetic aspects | Lung cancer, Non-small cell | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study
by Yock, Torunn I, Dr and Yeap, Beow Y, ScD and Ebb, David H, MD and Weyman, Elizabeth, BS and Eaton, Bree R, MD and Sherry, Nicole A, MD and Jones, Robin M, MD and MacDonald, Shannon M, MD and Pulsifer, Margaret B, PhD and Lavally, Beverly, RN and Abrams, Annah N, MD and Huang, Mary S, MD and Marcus, Karen J, MD and Tarbell, Nancy J, Prof
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 287 - 298
Hematology, Oncology and Palliative Medicine | Confidence Intervals | Prognosis | Age Factors | Cerebellar Neoplasms - diagnosis | Humans | Child, Preschool | Magnetic Resonance Imaging - methods | Male | Medulloblastoma - mortality | Young Adult | Medulloblastoma - radiotherapy | Time Factors | Neoplasm Invasiveness - pathology | Female | Child | Radiotherapy Dosage | Risk Assessment | Cerebellar Neoplasms - mortality | Kaplan-Meier Estimate | Medulloblastoma - diagnosis | Treatment Outcome | Disease-Free Survival | Proton Therapy | Adolescent | Sex Factors | Survival Analysis | Neoplasm Staging | Cerebellar Neoplasms - radiotherapy | Pediatrics | Radiotherapy | Health aspects | Analysis | Medulloblastoma | Radiation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer
by Cardarella, Stephanie and Ogino, Atsuko and Nishino, Mizuki and Butaney, Mohit and Shen, Jeanne and Lydon, Christine and Yeap, Beow Y and Sholl, Lynette M and Johnson, Bruce E and Jänne, Pasi A
Clinical cancer research, ISSN 1078-0432, 08/2013, Volume 19, Issue 16, pp. 4532 - 4540
Life Sciences & Biomedicine | Oncology | Science & Technology | Pharmacology. Drug treatments | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Pneumology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Prognosis | Carcinoma, Non-Small-Cell Lung - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Risk Factors | Genotype | Lung Neoplasms - pathology | Male | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Codon | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Aged, 80 and over | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
by Alice T. Shaw and Beow Y. Yeap and Mari Mino-Kenudson and Subba R. Digumarthy and Daniel B. Costa and Rebecca S. Heist and Benjamin Solomon and Hannah Stubbs and Sonal Admane and Ultan McDermott and Jeffrey Settleman and Susumu Kobayashi and Eugene J. Mark and Scott J. Rodig and Lucian R. Chirieac and Eunice L. Kwak and Thomas J. Lynch and A. John Iafrate
Journal of clinical oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 26, pp. 4247 - 4253
Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Erlotinib Hydrochloride | Immunohistochemistry | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Oncogene Proteins, Fusion - metabolism | Age Factors | Protein-Tyrosine Kinases - metabolism | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Protein-Tyrosine Kinases - genetics | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Genes, ras - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Genotype | In Situ Hybridization, Fluorescence | Treatment Outcome | Receptor Protein-Tyrosine Kinases | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Oncogene Proteins, Fusion - genetics | Sex Factors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Index Medicus | Original Reports | Thoracic Oncology | Thor12 | To8 | To20
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
by Scott J. Rodig and Mari Mino-Kenudson and Sanja Dacic and Beow Y. Yeap and Alice Shaw and Justine A. Barletta and Hannah Stubbs and Kenny Law and Neal Lindeman and Eugene Mark and Pasi A. Janne and Thomas Lynch and Bruce E. Johnson and A. John Iafrate and Lucian R. Chirieac
Clinical cancer research, ISSN 1078-0432, 08/2009, Volume 15, Issue 16, pp. 5216 - 5223
ALK | lung cancer | FISH | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Pneumology | Adenocarcinoma - pathology | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | Middle Aged | Lung Neoplasms - pathology | Male | Mutation - physiology | Protein-Tyrosine Kinases - genetics | Adenocarcinoma - metabolism | DNA Mutational Analysis | Aged, 80 and over | Germ-Line Mutation | Adult | Female | Adenocarcinoma - genetics | Cytogenetic Analysis | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Genetics, Population | Carcinoma, Non-Small-Cell Lung - surgery | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Western World | Receptor Protein-Tyrosine Kinases | Lung Neoplasms - surgery | Aged | Adenocarcinoma - surgery | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Long‐term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas
by DeLaney, Thomas F and Liebsch, Norbert J and Pedlow, Frank X and Adams, Judith and Weyman, Elizabeth A and Yeap, Beow Y and Depauw, Nicolas and Nielsen, G. Petur and Harmon, David C and Yoon, Sam S and Chen, Yen‐Lin and Schwab, Joseph H and Hornicek, Francis J
Journal of surgical oncology, ISSN 0022-4790, 08/2014, Volume 110, Issue 2, pp. 115 - 122
proton radiotherapy | spine | sarcoma | chordoma | Oncology | Life Sciences & Biomedicine | Surgery | Science & Technology | Chondrosarcoma - surgery | Prospective Studies | Follow-Up Studies | Chondrosarcoma - mortality | Chordoma - radiotherapy | Humans | Middle Aged | Proton Therapy - adverse effects | Young Adult | Thoracic Vertebrae - surgery | Lumbar Vertebrae - surgery | Radiotherapy, Adjuvant - adverse effects | Sacrum - surgery | Sarcoma - mortality | Aged, 80 and over | Adult | Sarcoma - radiotherapy | Spinal Neoplasms - radiotherapy | Chondrosarcoma - radiotherapy | Chordoma - surgery | Photons - adverse effects | Kaplan-Meier Estimate | Survival Rate | Treatment Outcome | Photons - therapeutic use | Sarcoma - surgery | Adolescent | Aged | Chordoma - mortality | Spine - surgery | Spinal Neoplasms - surgery | Radiotherapy, Conformal - methods | Sarcoma | Clinical trials | Radiotherapy | Medical research | Radiation therapy | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Prognostic significance of grading in lung adenocarcinoma
by Barletta, Justine A and Yeap, Beow Y and Chirieac, Lucian R
Cancer, ISSN 0008-543X, 02/2010, Volume 116, Issue 3, pp. 659 - 669
grading | prognosis | lung adenocarcinoma | survival | Prognosis | Lung adenocarcinoma | Grading | Survival | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Carcinoma, Non-Small-Cell Lung - pathology | Adenocarcinoma - pathology | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Lymphatic Metastasis | Carcinoma, Non-Small-Cell Lung - mortality | Mitotic Index | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Cell Differentiation | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma | Care and treatment | Research | Patient outcomes | Lung cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non–Small Cell Lung Cancer
by Yanan Kuang and Andrew Rogers and Beow Y. Yeap and Lilin Wang and Mike Makrigiorgos and Kristi Vetrand and Sara Thiede and Robert J. Distel and Pasi A. Jänne
Clinical cancer research, ISSN 1078-0432, 04/2009, Volume 15, Issue 8, pp. 2630 - 2636
Non-Small-Cell lung | epidermal growth factor receptor | drug resistance | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Pneumology | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - enzymology | Humans | DNA, Neoplasm - isolation & purification | Male | DNA Mutational Analysis - methods | Drug Resistance, Neoplasm - genetics | DNA, Neoplasm - blood | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Female | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | DNA, Neoplasm - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text EGFR mutations and ALK rearrangements are associated with low response rates to PD-1 pathway blockade in non-small cell lung cancer: A retrospective analysis
by Gainor, Justin F and Shaw, Alice T and Sequist, Lecia V and Fu, Xiujun and Azzoli, Christopher G and Piotrowska, Zofia and Huynh, Tiffany G and Zhao, Ling and Fulton, Linnea and Schultz, Katherine R and Howe, Emily and Farago, Anna F and Sullivan, Ryan J and Stone, James R and Digumarthy, Subba and Moran, Teresa and Hata, Aaron N and Yagi, Yukako and Yeap, Beow Y and Engelman, Jeffrey A and Mino-Kenudson, Mari
Clinical cancer research, ISSN 1078-0432, 09/2016, Volume 22, Issue 18, pp. 4585 - 4593
Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Translocation, Genetic | Humans | Lung Neoplasms - metabolism | Middle Aged | ErbB Receptors - genetics | Male | Tomography, X-Ray Computed | Carcinoma, Non-Small-Cell Lung - diagnosis | Molecular Targeted Therapy | Anaplastic Lymphoma Kinase | DNA Mutational Analysis | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Programmed Cell Death 1 Receptor - metabolism | Genotype | Treatment Outcome | Lymphocytes, Tumor-Infiltrating - drug effects | Antineoplastic Agents, Immunological - pharmacology | B7-H1 Antigen - metabolism | Receptor Protein-Tyrosine Kinases - genetics | Signal Transduction - drug effects | Antineoplastic Agents, Immunological - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Lung Neoplasms - diagnosis | Lymphocytes, Tumor-Infiltrating - immunology | Index Medicus | ALK | PD-1 Inhibitors | EGFR | Non-small cell lung cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection
by Sugarbaker, David J., MD and Gill, Ritu R., MD and Yeap, Beow Y., ScD and Wolf, Andrea S., MD, MPH and DaSilva, Marcelo C., MD and Baldini, Elizabeth H., MD, MPH and Bueno, Raphael, MD and Richards, William G., PhD
The Journal of thoracic and cardiovascular surgery, ISSN 0022-5223, 2013, Volume 145, Issue 4, pp. 955 - 963
Cardiothoracic Surgery | Humans | Middle Aged | Male | Mesothelioma - mortality | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Pleural Neoplasms - drug therapy | Mesothelioma - surgery | Time Factors | Hyperthermia, Induced | Aged, 80 and over | Adult | Female | Retrospective Studies | Mesothelioma - therapy | Neoplasm Recurrence, Local - prevention & control | Pleural Neoplasms - surgery | Risk Factors | Survival Rate | Combined Modality Therapy | Pleural Neoplasms - mortality | Pleural Neoplasms - therapy | Mesothelioma - drug therapy | Pneumonectomy - methods | Intraoperative Care - methods | Aged | Antimitotic agents | Chemotherapy | Nuclear radiation | Patient outcomes | Surgery | Mesothelioma | Antineoplastic agents | Cancer | Medical research | Algorithms | Medicine, Experimental | Hemoglobin | Rankings | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Merkel Cell Carcinoma: 30-Year Experience from a Single Institution
by Santamaria-Barria, Juan A and Santamaria-Barria, Juan A and Boland, Genevieve M and Boland, Genevieve M and Yeap, Beow Y and Yeap, Beow Y and Nardi, Valentina and Nardi, Valentina and Dias-Santagata, Dora and Dias-Santagata, Dora and Cusack Jr, James C and Cusack Jr, James C
Annals of surgical oncology, ISSN 1068-9265, 4/2013, Volume 20, Issue 4, pp. 1365 - 1373
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | Life Sciences & Biomedicine | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Carcinoma, Merkel Cell - therapy | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Neoplasm Micrometastasis | Time Factors | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Skin Neoplasms - pathology | Skin Neoplasms - therapy | Neoplasm Recurrence, Local - therapy | Survival Rate | Combined Modality Therapy | Lymphatic Metastasis | Carcinoma, Merkel Cell - mortality | Aged | Sentinel Lymph Node Biopsy | Neoplasm Staging | Carcinoma, Merkel Cell - pathology | Medical colleges | Carcinoma | Analysis | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights